SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-340611
Filing Date
2021-11-26
Accepted
2021-11-24 20:54:35
Documents
15
Period of Report
2021-10-28
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d178059d8ka.htm   iXBRL 8-K/A 29185
2 EX-99.1 d178059dex991.htm EX-99.1 165339
3 EX-99.2 d178059dex992.htm EX-99.2 61191
4 EX-99.3 d178059dex993.htm EX-99.3 277114
  Complete submission text file 0001193125-21-340611.txt   713403

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bttx-20211028.xsd EX-101.SCH 2916
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bttx-20211028_lab.xml EX-101.LAB 18836
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bttx-20211028_pre.xml EX-101.PRE 11861
8 EXTRACTED XBRL INSTANCE DOCUMENT d178059d8ka_htm.xml XML 4210
Mailing Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036
Business Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036 646-493-6558
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1028
Type: 8-K/A | Act: 34 | File No.: 001-39864 | Film No.: 211448899
SIC: 8000 Services-Health Services